COLL
Collegium Pharmaceutical Inc
22.10$
+0.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +219.4% | +66.7% | +63.9% | +235.7% | -9.7% | +490.6% | +14.6% | -3.9% | +4.6% | +1.5% | +0.7% | -2.8% | +1.7% | +3.1% | +2.0% | +1.4% | -3.7% | +15.0% | -5.4% | -4.9% | -65.3% | +206.1% | +47.5% | +2.8% | +2.1% | +11.7% | -6.4% | +0.9% | +9.5% | -3.2% | +0.2% | +9.7% | +14.2% | -2.3% | +5.8% | +11.4% | -1.9% | -5.8% | +3.3% | – | |
| – | +534.5% | +101.6% | +55.5% | -4.2% | +97.8% | +3,840.2% | +8.7% | -1.8% | -35.4% | +65.4% | -1.0% | -3.9% | +5.0% | -23.6% | -20.9% | +4.3% | +3.2% | +0.5% | +1.8% | +0.1% | -12.3% | +22.9% | +101.9% | -4.2% | +17.1% | -15.6% | -8.4% | -8.6% | -2.3% | -3.0% | +1.9% | +14.8% | +33.8% | -3.9% | -1.0% | +0.7% | -3.9% | -1.0% | +17.5% | – | |
| – | +195.3% | +60.9% | +65.6% | +282.1% | -14.9% | +112.8% | +27.0% | -7.8% | +80.8% | -42.0% | +4.1% | -0.8% | -4.1% | +55.2% | +24.1% | -0.4% | -8.1% | +25.5% | -9.6% | -8.2% | -102.9% | – | +8.0% | +12.4% | -15.4% | +55.5% | -4.6% | +8.8% | +17.8% | -3.4% | -0.7% | +6.6% | +1.5% | -1.0% | +11.4% | +19.2% | -0.6% | -8.7% | -5.9% | – | |
| – | +2.4% | -36.1% | +2.3% | -5.0% | +6.0% | +3.4% | -1.4% | -14.8% | +17.9% | +33.0% | -17.8% | +1.3% | -3.7% | +11.2% | -6.5% | -14.1% | +15.5% | +18.5% | +18.2% | -58.1% | +11.0% | +147.5% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +20.5% | -19.6% | -3.4% | +3.2% | +11.2% | +24.8% | -1.0% | +6.9% | -9.0% | +6.2% | -10.6% | +3.9% | -16.6% | +24.6% | -6.2% | -9.9% | +330.8% | -72.3% | -3.5% | +0.5% | -26.5% | +143.3% | -24.3% | -7.0% | -31.5% | +100.7% | -27.6% | -7.6% | -27.7% | +64.4% | +3.2% | +43.0% | -22.5% | +59.3% | -3.6% | -8.9% | +0.8% | +27.7% | +23.4% | – | |
| – | +7.0% | -13.0% | -2.9% | +2.4% | +9.9% | +24.1% | -1.0% | +5.5% | -7.5% | +8.1% | -11.2% | +3.7% | -15.6% | +23.4% | -6.2% | -10.2% | +2.6% | +17.4% | -1.7% | -5.5% | +2.6% | +78.4% | -29.5% | -7.0% | -0.9% | +38.8% | -27.6% | -7.6% | -6.7% | +27.4% | +3.2% | +43.0% | -2.9% | +25.7% | -3.1% | -10.5% | +5.5% | +23.3% | +25.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -190.8% | – | – | – | – | +227.0% | +18.6% | -23.6% | +41.3% | -22.6% | -13.8% | -341.2% | – | – | +84.2% | -42.6% | +109.5% | +44.7% | +26.3% | +37.0% | -19.8% | -4.0% | -26.6% | +9.4% | -43.1% | +61.9% | +81.2% | -6.9% | -46.0% | -88.4% | – | |
| – | +850.0% | +415.8% | +39.8% | +21.9% | +7.8% | +3,066.7% | +8.0% | -4.7% | -59.0% | -90.3% | +0.9% | -3.4% | -7.5% | +2,185.8% | +71.2% | -2.4% | -4.0% | -26.1% | -5.2% | -5.6% | -7.0% | +22.6% | +204.6% | +7.2% | +8.0% | +4.1% | +2.0% | -5.0% | -7.2% | -10.1% | -10.1% | +18.0% | +23.2% | -8.2% | -1.6% | +6.4% | +381.4% | -84.9% | +23.1% | – | |
| – | – | – | – | – | – | – | – | – | – | -206.8% | – | – | – | – | +1,745.3% | +39.3% | -37.2% | +113.1% | -29.0% | -17.8% | -530.2% | – | – | – | -644.1% | – | – | +61.7% | +62.3% | -21.6% | -20.5% | -46.5% | +10.8% | -81.9% | +445.3% | +155.1% | -33.2% | -35.5% | -172.2% | – | |
| – | -1,050.0% | – | – | – | – | – | +8.0% | -4.7% | -67.4% | -115.2% | – | – | – | +2,085.3% | -94.7% | +13.8% | +8.6% | -161.8% | – | – | -1,496.8% | – | – | – | -160.7% | – | – | +70.1% | +81.2% | -39.7% | +6.5% | -34.2% | -24.2% | -85.1% | +615.2% | +136.6% | +1.2% | -64.8% | -64.2% | – | |
| – | – | – | – | – | – | – | – | – | – | -206.8% | – | – | – | – | +1,690.7% | +40.1% | -38.3% | +125.1% | +365.1% | -89.0% | -411.1% | – | – | – | -1,675.3% | – | – | +58.6% | +54.8% | -13.2% | -29.3% | -52.4% | +34.3% | -80.7% | +395.8% | +162.9% | -46.2% | -14.5% | -203.8% | – | |
| – | – | – | – | – | – | – | +50.1% | -14.4% | +24.6% | -120.5% | – | – | – | +732.4% | +112.8% | +9.1% | -12.4% | +19.8% | -12.5% | -6.6% | -153.8% | – | +414.6% | +17.9% | -4.4% | -24.8% | +85.3% | +11.2% | +17.1% | -11.9% | -10.3% | -5.5% | +27.4% | -16.5% | +16.9% | +29.3% | +56.3% | -52.6% | -20.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.